Norethindrone-acetate-Standard-生命科學(xué)試劑-MCE

Hotline:400-820-3792Inhibitors?ScreeningLibraries?Proteinswww.MedChemENorethindroneacetate(Standard)Cat.No.:HY-B1710RCASNo.:51-98-9分?式:C??H??O?分?量:340.46作?靶點(diǎn):ProgesteroneReceptor作?通路:VitaminDRelated/NuclearReceptor儲(chǔ)存?式:PleasestoretheproductundertherecommendedconditionsintheCertificateofAnalysis.BIOLOGICALACTIVITY?物活性Norethindroneacetate(Standard)Norethindroneacetate的分析標(biāo)準(zhǔn)品。本產(chǎn)品?于研究及分析應(yīng)?。Norethindroneacetate?種雌性激素，可?于?宮內(nèi)膜異位癥研究。Norethindroneacetate?種點(diǎn)擊化學(xué)試劑。它含有Alkyne團(tuán)，可以和含有Azide團(tuán)的分?發(fā)?銅催化的疊氮-炔環(huán)加成反應(yīng)(CuAAc)。IC50&TargetProgesteroneReceptor[1]REFERENCES[1].Muneyyirci-DelaleO,etal.Effectofnorethindroneacetateinthetreatmentofsymptomaticendometriosis.IntJFertilWomensMed.1998Jan-Feb;43(1):24-7.[2].KaserDJ,etal.Useofnorethindroneacetatealoneforpostoperativesuppressionofendometriosissymptoms.JPediatrAdolescGynecol.2012Apr;25(2):105-8.[3].MaierWE,etal.Pharmacologyandtoxicologyofethinylestradiolandnorethindroneacetateinexperimentalanimals.RegulToxicolPharmacol.2001Aug;34(1):53-61.[4].ChengDC,etal.Norethindroneacetateinhibitionoftriglyceridesynthesisandreleasebyrathepatocytes.Atherosclerosis.1983Jan;46(1):41-8.McePdfHeightCaution:Producthasnotbeenfullyvalidatedformedicalapplications.Forresearchuseonly.Tel:400-820-3792ax:021-537